ACCESSWIRE
13 May 2022, 05:37 GMT+10
NASHUA, NH / ACCESSWIRE / May 12, 2022 / iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will present at the Spring Into Action - Best Ideas Virtual Investor Conference, which is being held virtually on May 16th - 20th, 2022.
Stacey Stevens, President and CEO of iCAD, Inc. will present on Tuesday, May 17, 2022, from 11:30 to 11:55 a.m. EST. iCAD management will be available for one-on-one meetings during the conference. The presentation will be webcast live and available for replay here: https://www.webcaster4.com/Webcast/Page/2882/45573
To receive additional information, request an invitation or schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.
Investors can register here.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD® is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Forward-Looking Statements
Certain statements contained in this News Release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expected benefits of ProFound AI®, the benefits of the Company's products, external factors affecting the market for our products, behavior of clients and prospective clients, and future prospects for the Company's technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company's ability to achieve business and strategic objectives, the willingness of patients to undergo mammography screening in light of risks of potential exposure to Covid-19, whether mammography screening will be treated as an essential procedure, whether ProFound AI will improve reading efficiency, improve specificity and sensitivity, reduce false positives and otherwise prove to be more beneficial for patients and clinicians, the impact of supply and manufacturing constraints or difficulties on our ability to fulfill our orders, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words 'believe,' 'demonstrate,' 'intend,' 'expect,' 'estimate,' 'will,' 'continue,' 'anticipate,' 'likely,' 'seek,' and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at http://www.icadmed.com and on the SEC's website at http://www.sec.gov.
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
SOURCE: iCAD, Inc.
Get a daily dose of Boston Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Boston Star.
More InformationSYDNEY, NSW, Australia - The euro has jumped above 1.0700 in Asian trading Tuesday, but stocks have fallen sharply.The run ...
MILAN, Italy: Netflix and Italy have agreed to a $59 million settlement to to settle a four-year tax dispute, Milan ...
LONDON, England: British consumers continued to shop as normal last month, despite the highest inflation rate in 40 years, with ...
NEW YORK, New York - U.S. stocks rocketed higher Monday, a rally ignited by a weakening of the U.S. dollar ...
WASHINGTON D.C.: Following baby formula shortages throughout the United States, FDA Commissioner Robert Califf has said that Abbott Laboratories and ...
NEW DELHI, India: Skyroot, India's first privately held company to design, build and test a solid rocket propulsion system, successfully ...
Jayson Tatum recorded 31 points, eight rebounds and five assists as the Boston Celtics dominated from the outset while notching ...
Boston Celtics point guard Marcus Smart will miss Monday night's Game 4 of the Eastern Conference finals against the visiting ...
The Golden State Warriors look to become the first team since Michael Jordan's Chicago Bulls to make six trips to ...
Boston Uprising parted ways Monday with veteran tank Min-seo "Marve1" Hwang over "personal issues." The 21-year-old South Korean joined the ...
After being outscored 32-15 by the New York Yankees while losing three of four during a May 12-15 home series, ...
Miami Heat guard Tyler Herro has been ruled out of Monday night's Game 4 against the Boston Celtics with a ...